Proteomics

Dataset Information

0

Myeloperoxidase is a Critical Mediator of Anthracycline-induced Cardiomyopathy


ABSTRACT: The anthracycline doxorubicin is a commonly used chemotherapeutic drug that induces cardiomyopathy in almost 10% of patients. The aim of this study was to examine the role of the leukocyte-derived enzyme Myeloperoxidase (MPO) in pathogenesis of anthracycline-induced Cardiomyopathy (AICM). We performed proteomics on whole heart tissue of MPO-deficient mice on C57BL/6J background and wildtype (WT) littermates seven days after intravenous injection of the anthracycline Doxorubicin (20 mg/kg bodyweight, dissolved in saline) or saline (NaCl).

INSTRUMENT(S): Orbitrap Exploris 480

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Heart

SUBMITTER: Prerana Wagle  

LAB HEAD: Martin Mollenhauer

PROVIDER: PXD037524 | Pride | 2023-08-30

REPOSITORIES: Pride

Similar Datasets

2022-11-15 | PXD031535 | Pride
2022-11-15 | PXD031552 | Pride
2023-10-24 | PXD041004 | Pride
2023-04-06 | PXD030159 | Pride
2023-04-06 | PXD035853 | Pride
2023-01-31 | PXD033836 | Pride
2023-09-29 | PXD045741 | Pride
2022-11-17 | PXD029198 | Pride
2023-03-11 | PXD033306 | Pride
2023-07-10 | PXD040305 | Pride